Home
Company Background
Senior Management
Board of Directors
Scientific Advisors
Collaborations
Contact Us
Overview
Prurisol
Kevetrin
Brilacidin
Therapeutic Areas
Stages of Development
FDA Designations
Stock Information
Financials & Filings
Corporate Governance
Investor FAQ
Welcome
Press Releases
Events and Presentations
Blog
Email Alerts
Stock Symbol: CTIX
Clinical Trials
Latest News
Contact Us
EMAIL ALERTS
Stock Symbol: CTIX
Clinical Trials
Latest News
Contact Us
EMAIL ALERTS

Cellceutix

Home
Company Background
Senior Management
Board of Directors
Scientific Advisors
Collaborations
Contact Us
Overview
Prurisol
Kevetrin
Brilacidin
Therapeutic Areas
Stages of Development
FDA Designations
Stock Information
Financials & Filings
Corporate Governance
Investor FAQ
Welcome
Press Releases
Events and Presentations
Blog
Email Alerts

STOCK INFORMATION

  • Investors
  • Stock Information
  • Financials & Filings
  • Corporate Governance
  • Investor FAQ
Back to Top
Contact Us
Email alerts

Follow Us

Legal

Forward-Looking Statements
Terms of Use
Privacy Policy
Social Media Disclosure

COPYRIGHT © CELLCEUTIX 2016

Cellceutix is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.

Click here for a Corporate Overview.